ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

Funding opportunities listed.

July 16, 2004

NCI Reports On Efforts To Prevent Cancer In Native Americans

August 13, 1999

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006

DCPC Board Okays Core Grant Changes On Shared Resources

January 30, 1987